Monitoring the blood circulation and blood flow in the patient’ brain is a highly essential criterion to be considered by medical professionals during advanced brain surgeries. This is facilitated by the usage of transcranial doppler (TCD) systems, which is a non-invasive method for monitoring blood flow. In recent years, the incidence of mental disorders and illness has proliferated across the world, owing to the changing lifestyles, environmental conditions, and aging population. As a result, the demand for brain monitoring devices is also increasing, thereby driving the growth of the TCD market.
The Asian market for TCD systems is the largest contributor in comparison to the global market, having accounted for a share of 79.34% in 2013. North America and Europe are two other major markets for TCD, having accounted for a market share of 12.62% and 6.03% in 2013. The global TCD market is projected to grow at a CAGR of 9.4%, from 2013 to 2018. Main applications for the TCD systems include emboli detection, sickle cell disease, and intracranial stenosis among others.
The North American and European regions encompass vast majorities of aging population. Therefore, the incidence of mental and brain disorders are higher in these regions. In Asia, changing lifestyle and diverse environmental conditions have led to brain disorders among the adolescent as well as elderly population. With technological advancements, the demand for more enhanced and efficient brain monitoring devices is increasing at a significant pace. These factors are considered as the main market drivers resulting in the growth of the global transcranial doppler market. In addition to these factors, worthy investments made in the healthcare sector by government and private players, along with the increasing number of mergers, acquisitions, and partnerships between the leading companies in this market, is also responsible for its progressive growth. Prominent market players include Integra LifeSciences (U.S.), Spiegelberg GmbH & Co. (Germany), Nihon Kohden Corporation (Japan), and Elekta (Sweden), among others.
The global transcranial doppler market report offers an overview on the market share, value chain analysis, and market dynamics such as drivers, restraints, and upcoming opportunities. The global transcranial doppler market is segmented on the basis of geography and application. North America, Europe, Asia, and Rest of the World (RoW) are the major regions that have been considered for this extensive market analysis. In terms of applications, the market has been segmented into emboli detection, subarachnoid hemorrhage, sickle cell disease, and intracranial stenosis.
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Applications
4.1 Emboli detection
4.2 Intracranial Stenosis
4.3 Subarachnoid Hemorrhage
4.4 Sickle Cell Disease
5 By Geographies
5.1 North America
5.4 Rest of World
6 By Companies
6.1 Nihon Kohden Corporation
6.2 Natus Medical Inc.
6.3 Grass technologies
6.4 Compumedics Limited
6.5 Cadwell Laboratories, Inc.
6.6 Rimed Ltd
6.8 Compumedics Germany GmbH
6.9 Yokogawa Electric
6.10 Integra LifeSciences Corporation
6.11 Spiegelberg GmbH & Co.
6.12 InnerSpace Neuro, Inc.
6.13 Headsense Medical, Ltd
6.14 Covidien Medical devices
6.15 Nonin Medical Inc.
6.16 CAS Medical Systems, Inc.
6.17 Other Companies
6.18 DePuy Synthes
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Emboli detection and Intracranial Stenosis, Subarachnoid...
Intracranial Stenosis and Emboli detection, Subarachnoid...
Subarachnoid Hemorrhage and Emboli detection, Intracranial...
Sickle Cell Disease
Sickle Cell Disease and Emboli detection, Intracranial...
North American Transcranial Dopplers (TCD)
The North American transcranial doppler market accounted for a market share of 12.62% share in 2013, and is considered as the second largest market in this segment. The rising incidence of brain/mental disorders, especially among the adolescent and aged population, has driven the demand for TCD and other brain monitoring devices in this region. The report offers noteworthy insights on the market share, value chain analysis, market segmentation, and competitive landscape of key industries in this market. It also presents an elaborated overview of company profiles, financials, and recent developments.
European Transcranial Dopplers (TCD)
The aging population in the region, along with the high incidence of brain disorders, is the most important reason for the growth of the European transcranial doppler market. The European market is projected to grow at a CAGR of 5.1%, from 2013 to 2018. The market report provides details of the market valuations, segmentation, competitive scenario, and drivers & restraints among others. Deep dive analysis of key market players are also considered in this report.
Asian Transcranial Dopplers (TCD)
The growing investments made in the research & development segment of the mental healthcare sector, along with growing incidences of mental disorders among the adolescent and elderly populations of this region, are the main factors driving the growth of the Asian transcranial doppler market. The market report provides insights into the market value forecasts, segmentation, market competition, drivers & restraints, and the strategic profiles of the key market players. Japan, China, and India are the major economies considered for market analysis.